Pedro Povoa

Summary

Country: Portugal

Publications

  1. ncbi What is the role of steroids in pneumonia therapy?
    Pedro Povoa
    Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal
    Curr Opin Infect Dis 25:199-204. 2012
  2. ncbi The role of corticosteroids in severe community-acquired pneumonia: a systematic review
    Jorge I F Salluh
    Intensive Care Unit, Instituto Nacional de Cancer, Rio de Janeiro, Brazil, Praça Cruz Vermelha, 23, 10 andar Centro, 20230 130 Rio de Janeiro RJ
    Crit Care 12:R76. 2008
  3. ncbi C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study
    Pedro Povoa
    Polyvalent Intensive Care Unit, São Francisco Xavier Hospital, CHLO, Estrada do Forte do Alto do Duque, 1449 005 Lisbon, Portugal
    Crit Care 15:R169. 2011
  4. ncbi C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia
    Pedro Povoa
    Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Estrada do Forte do Alto do Duque, Lisbon, Portugal
    Crit Care 15:R129. 2011
  5. ncbi Treatment of candidemia in adult patients without neutropenia--an inconvenient truth
    Pedro Povoa
    Unidade de Cuidados Intensivos Polivalente, Hospital São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, EPE, Estrada do Forte do Alto do Duque, 1449 005 Lisboa, Portugal
    Crit Care 15:114. 2011
  6. ncbi Adrenergic support in septic shock: a critical review
    Pedro Povoa
    Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Medical Sciences Faculty, New University of Lisbon, Lisboa, Portugal
    Hosp Pract (Minneap) 38:62-73. 2010
  7. ncbi Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study)
    Pedro R Póvoa
    Medical Intensive Care Unit, São Francisco Xavier Hospital, Lisbon, Portugal
    Crit Care Med 37:410-6. 2009
  8. ncbi Serum markers in community-acquired pneumonia and ventilator-associated pneumonia
    Pedro Povoa
    Faculty of Medical Sciences, New University of Lisbon, Medical Intensive Care Unit, Department of Medicine, São Francisco Xavier Hospital, Lisbon, Portugal
    Curr Opin Infect Dis 21:157-62. 2008
  9. ncbi C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study
    P Povoa
    Intensive Care Unit, Garcia de Orta Hospital, 2800 525 Almada, Portugal
    Eur Respir J 25:804-12. 2005
  10. ncbi Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study
    Pedro Povoa
    Unidade de Cuidados Intensivos, Hospital Garcia de Orta, Almada, Portugal
    Crit Care 10:R63. 2006

Collaborators

Detail Information

Publications19

  1. ncbi What is the role of steroids in pneumonia therapy?
    Pedro Povoa
    Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal
    Curr Opin Infect Dis 25:199-204. 2012
    ....
  2. ncbi The role of corticosteroids in severe community-acquired pneumonia: a systematic review
    Jorge I F Salluh
    Intensive Care Unit, Instituto Nacional de Cancer, Rio de Janeiro, Brazil, Praça Cruz Vermelha, 23, 10 andar Centro, 20230 130 Rio de Janeiro RJ
    Crit Care 12:R76. 2008
    ..The purpose of this review was to evaluate the impact of corticosteroids on the outcomes of patients with severe community-acquired pneumonia (CAP)...
  3. ncbi C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study
    Pedro Povoa
    Polyvalent Intensive Care Unit, São Francisco Xavier Hospital, CHLO, Estrada do Forte do Alto do Duque, 1449 005 Lisbon, Portugal
    Crit Care 15:R169. 2011
    ..Our objective was to evaluate serial CRP measurements after prescription of antibiotics to describe the clinical course of Community-Acquired Sepsis admitted to intensive care units (ICU)...
  4. ncbi C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia
    Pedro Povoa
    Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Estrada do Forte do Alto do Duque, Lisbon, Portugal
    Crit Care 15:R129. 2011
    ..Several biomarkers have been studied in febrile neutropenia. Our aim was to assess C-reactive protein (CRP) concentration in septic critically ill cancer patients and to compare those with and without neutropenia...
  5. ncbi Treatment of candidemia in adult patients without neutropenia--an inconvenient truth
    Pedro Povoa
    Unidade de Cuidados Intensivos Polivalente, Hospital São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, EPE, Estrada do Forte do Alto do Duque, 1449 005 Lisboa, Portugal
    Crit Care 15:114. 2011
    ..In this document the preferred treatment was either fluconazole or an echinocandin. Amphotericin-B formulations were considered an alternative. However, careful assessment of published data showed similar efficacy between these drugs...
  6. ncbi Adrenergic support in septic shock: a critical review
    Pedro Povoa
    Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Medical Sciences Faculty, New University of Lisbon, Lisboa, Portugal
    Hosp Pract (Minneap) 38:62-73. 2010
    ..As a result, our view on the prescription of vasopressors has changed from a probably oversimplified "one-size-fits-all" approach to a multimodal approach in vasopressor selection...
  7. ncbi Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study)
    Pedro R Póvoa
    Medical Intensive Care Unit, São Francisco Xavier Hospital, Lisbon, Portugal
    Crit Care Med 37:410-6. 2009
    ..Guidelines for the adrenergic support of septic shock are controversial. In patients with community-acquired septic shock, we assessed the impact of the choice of vasopressor support on mortality...
  8. ncbi Serum markers in community-acquired pneumonia and ventilator-associated pneumonia
    Pedro Povoa
    Faculty of Medical Sciences, New University of Lisbon, Medical Intensive Care Unit, Department of Medicine, São Francisco Xavier Hospital, Lisbon, Portugal
    Curr Opin Infect Dis 21:157-62. 2008
    ..This article reviews recent data on the usefulness of serum markers in community-acquired pneumonia and ventilator-associated pneumonia. The focus is on clinical studies, with an emphasis on adult critically ill patients...
  9. ncbi C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study
    P Povoa
    Intensive Care Unit, Garcia de Orta Hospital, 2800 525 Almada, Portugal
    Eur Respir J 25:804-12. 2005
    ..The identification of the pattern of C-reactive protein response to antibiotics was useful in the recognition of individual clinical course, improving or worsening, as well as of the rate of improvement...
  10. ncbi Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study
    Pedro Povoa
    Unidade de Cuidados Intensivos, Hospital Garcia de Orta, Almada, Portugal
    Crit Care 10:R63. 2006
    ..Our aim was to assess the value of daily measurements of C-reactive protein (CRP), temperature and white cell count (WCC) in the early identification of intensive care unit (ICU)-acquired infections...
  11. ncbi Evaluation of a recruitment maneuver with positive inspiratory pressure and high PEEP in patients with severe ARDS
    P Povoa
    Unidade de Cuidados Intensivos, Hospital Garcia de Orta, Pragal, Almada, Portugal
    Acta Anaesthesiol Scand 48:287-93. 2004
    ....
  12. ncbi Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection
    Pedro Povoa
    Unidade de Cuidados Intensivos, Hospital Garcia de Orta, Almada, Portugal
    Clin Infect Dis 40:1855-7. 2005
    ..A CRP ratio of >0.58 at day 4 of therapy was a marker of poor outcome (sensitivity, 0.89; specificity, 0.69). The recognition of a pattern of CRP-ratio response was useful in the prediction of individual clinical course...
  13. ncbi C-reactive protein as a marker of infection in critically ill patients
    P Povoa
    Unidade de Cuidados Intensivos, Hospital Garcia de Orta, Almada, Portugal
    Clin Microbiol Infect 11:101-8. 2005
    ..However, the combination of CRP and temperature measurements further increased the specificity for infection diagnosis, even in the subgroup of patients with VAP...
  14. ncbi Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course
    Luis Coelho
    Unidade de Cuidados Intensivos, Hospital Garcia de Orta, Almada, Portugal
    Crit Care 11:R92. 2007
    ....
  15. ncbi Assessment of risk factors for in-hospital mortality after intensive care unit discharge
    Inês Araújo
    Polyvalent Intensive Care Unit, São Francisco Xavier Hospital, CHLO, Lisboa, Portugal
    Biomarkers 17:180-5. 2012
    ..Post-intensive care unit (ICU) mortality predictors are unknown...
  16. ncbi Metformin-induced lactic acidosis: a case series
    Joana Silvestre
    Department of Medicine III, Unidade de Cuidados Intensivos Médicos, Servico de Medicina III, Hospital São Francisco Xavier, Portugal
    J Med Case Reports 1:126. 2007
    ..The reported frequency of metformin related lactic acidosis is 0.05 per 1000 patient-years; some authors advocate that this rate is equal in those patients not taking metformin...
  17. ncbi Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of ?-lactams
    João Gonçalves-Pereira
    Polyvalent Intensive Care Unit, São Francisco Xavier Hospital, Estrada do Forte do Alto do Duque, 1449 005 Lisboa, Portugal
    Crit Care 15:R206. 2011
    ....
  18. ncbi Should C-reactive protein concentration at ICU discharge be used as a prognostic marker?
    Joana Silvestre
    Polyvalent Intensive Care Unit, São Francisco Xavier Hospital, Cedoc, Faculty of Medical Sciences, New University of Lisbon, Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Estrada do Forte do Alto do Duque, 1449 005 Lisboa, Portugal
    BMC Anesthesiol 10:17. 2010
    ..Some authors have recently hypothesized that unresolved or latent inflammation and sepsis may be an important factor that contributes to death following successful discharge from the ICU...